SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-313330
Filing Date
2013-08-01
Accepted
2013-07-31 20:31:07
Documents
4
Period of Report
2013-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d577014d8k.htm 8-K 38605
2 EX-2.1 d577014dex21.htm EX-2.1 588880
3 EX-2.2 d577014dex22.htm EX-2.2 49056
4 EX-2.3 d577014dex23.htm EX-2.3 78151
  Complete submission text file 0001193125-13-313330.txt   755799
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 131000603
SIC: 2834 Pharmaceutical Preparations